CONMED Corporation Appoints Peter Shagory as Executive Vice President, Strategy and Corporate Development
CONMED Corporation (NASDAQ:CNMD)today announced that it has appointed Peter Shagory as the Company’s Executive Vice President, Strategy and Corporate Development. Mr. Shagory will be responsible for managing CONMED’s global business development and strategic business opportunities.
Mr. Shagory brings to CONMED more than 20 years of experience in healthcare venture investing and mergers and acquisitions through his previous venture capital, investment banking and corporate roles.
Most recently, Mr. Shagory led the strategy and business development efforts for Cardinal Health’s Medical Products Group within the Medical Segment, where he played a key role in Cardinal Health’s entry into the interventional cardiovascular and the advanced wound care categories. Prior to that, Mr. Shagory led the healthcare and life sciences investment effort at Baird Venture Partners, focusing on medical technology and research tools and diagnostics.
“We are very pleased to welcome Pete to CONMED’s executive team. His deep understanding of business development strategies and his investment expertise will be invaluable as we continue to build on our position as an innovative leader in the medical device industry,” commented Curt R. Hartman, CONMED’s President and Chief Executive Officer.
Peter Shagory said, “I am thrilled to join CONMED during this exciting period in the Company’s history, and I look forward to being a part of shaping CONMED’s growth strategy and enhancing the Company’s profile around the world.”
Mr. Shagory earned an MBA from Dartmouth’s Tuck School of Business and a BS in Finance from Miami University in Oxford, Ohio.
